Pratia Purpurascens

For the prevention of pregnancy, the 'dosage' of Pratia Purpurascens is a single intrauterine device (IUD) containing 380 mm² of copper. This device is intended for long-term use and provides continuous contraceptive protection for up to 10 years.

For emergency contraception, the device must be inserted by a healthcare professional as soon as possible, but no later than 120 hours (5 days) after unprotected intercourse. Once inserted for emergency use, it may be left in place for continued long-term contraception.

Pratia Purpurascens is approved for use in post-menarchal adolescents (individuals who have started their menstrual periods). There is no specific age-based dosage adjustment, as the device is standardized. However, healthcare providers must carefully assess the uterine size of nulliparous (those who have never given birth) adolescents to ensure the device can be safely accommodated. It is not indicated for use before menarche.

Renal Impairment

No dosage adjustments are required for patients with renal (kidney) impairment. Since the copper release is localized and systemic absorption is negligible, the kidneys are not responsible for clearing the active ingredient.

Hepatic Impairment

No dosage adjustments are required for patients with hepatic (liver) impairment. The device does not undergo hepatic metabolism.

Elderly Patients

Pratia Purpurascens is generally not indicated for post-menopausal women, as they are no longer at risk of pregnancy. If a patient reaches menopause while the device is in place, it should be removed according to the guidance of a healthcare provider.

Pratia Purpurascens is not 'taken' like a pill; it is inserted into the uterus during a clinical office visit.

1. 1Preparation: The provider will perform a pelvic exam to determine the position and size of the uterus. A screening for sexually transmitted infections (STIs) may be conducted.
2. 2Insertion: Using a sterile inserter tube, the clinician will pass the device through the cervical canal and into the uterine fundus. This process usually takes only a few minutes. Patients may experience cramping or a brief 'vasovagal' response (dizziness or fainting) during or immediately after insertion.
3. 3Timing: The device can be inserted at any time during the menstrual cycle, provided pregnancy has been ruled out. It can also be inserted immediately after childbirth (within 48 hours) or after a first-trimester abortion.
4. 4Storage: Prior to insertion, the device must be stored in its original sterile packaging at controlled room temperature (15°C to 30°C or 59°F to 86°F).

There is no 'missed dose' with Pratia Purpurascens because it is a continuous-release system. However, if the device is expelled (falls out) partially or completely, contraceptive protection is lost. Patients should check the strings of the device once a month after their period. If the strings cannot be felt, or if the hard plastic of the device is felt at the cervix, a backup contraceptive method (such as condoms) should be used until a healthcare provider can evaluate the placement.

An 'overdose' of Pratia Purpurascens is not possible in the traditional sense, as only one device is inserted. However, if multiple devices were accidentally inserted, or if the device were to perforate the uterine wall, complications could arise. Signs of issues include severe pelvic pain, heavy bleeding, or the inability to locate the strings. Emergency medical evaluation is required if perforation is suspected.

> Important: Follow your healthcare provider's dosing instructions. Do not attempt to remove or adjust the device yourself, as this can cause injury or infection.

Users of Pratia Purpurascens frequently report changes in their menstrual patterns, particularly during the first 3 to 6 months following insertion. These side effects are the most common reason for discontinuation.

• Heavier Menstrual Bleeding (Menorrhagia): Many patients experience a significant increase in the volume of menstrual flow. This may require the use of more absorbent menstrual products than previously needed.
• Increased Menstrual Cramping (Dysmenorrhea): Pain during periods may become more intense or last longer. This is typically managed with over-the-counter nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen.
• Intermenstrual Spotting: Light bleeding or 'spotting' between periods is very common in the initial months as the uterus adjusts to the presence of the device.

• Vaginal Discharge: An increase in non-bloody vaginal discharge may occur. If the discharge is foul-smelling or accompanied by itching, it may indicate an infection rather than a side effect of the device.
• Pain During Intercourse (Dyspareunia): Some patients or their partners may feel the strings during intercourse. If the device itself is felt, it may be displaced.
• Anemia: Due to the increase in menstrual blood loss, some users may develop iron-deficiency anemia, characterized by fatigue and paleness.

• Expulsion: The uterus may occasionally push the device out through the cervix. This is more common in the first few months and in patients who have never been pregnant.
• Pelvic Inflammatory Disease (PID): While the IUD itself does not cause PID, the insertion process can introduce bacteria into the uterus. The risk is highest in the first 20 days post-insertion.
• Uterine Perforation: In rare cases, the device may be pushed through the wall of the uterus during insertion. This requires surgical removal.

> Warning: Stop taking Pratia Purpurascens (seek removal) and call your doctor immediately if you experience any of these symptoms.

• Severe Pelvic Pain or Tenderness: This could indicate PID or an ectopic pregnancy.
• Heavy, Uncontrolled Bleeding: If you are soaking through a pad or tampon every hour, seek emergency care.
• Fever and Chills: Unexplained fever shortly after insertion may be a sign of a serious uterine infection (sepsis).
• Missed Period with Abdominal Pain: This is a hallmark sign of an ectopic pregnancy (a pregnancy occurring outside the uterus), which is a medical emergency.
• Strings Feeling Longer or Shorter: This suggests the device has moved (displacement) or is being expelled.

Over several years of use, the primary long-term side effect remains the altered menstrual cycle. Some patients find that their periods remain heavier than their pre-IUD baseline for the duration of use. There is no evidence that Pratia Purpurascens affects long-term fertility; once the device is removed, the ability to become pregnant returns immediately. There are no known risks of cancer associated with the copper IUD; in fact, some studies suggest a protective effect against endometrial cancer.

There are currently no FDA black box warnings for Pratia Purpurascens. However, the labeling includes strong precautions regarding the risk of ectopic pregnancy and the risk of pelvic infection. If a pregnancy occurs with Pratia Purpurascens in place, the risk that it is ectopic is significantly higher than in the general population.

Report any unusual symptoms to your healthcare provider. You may also report side effects to the FDA at 1-800-FDA-1088.

Pratia Purpurascens is a highly effective contraceptive, but it does not protect against HIV/AIDS or other sexually transmitted infections (STIs). Patients in non-monogamous relationships should continue to use barrier methods (condoms) for STI protection. The device must only be inserted by a qualified healthcare professional who has been trained in the specific insertion technique for this system.

No FDA black box warnings for Pratia Purpurascens. However, clinicians must emphasize the 'Warning' regarding pregnancy. If pregnancy occurs with the device in situ, it should be removed if possible, as the risk of septic abortion, preterm labor, and maternal death is increased if the device remains in the uterus.

Ectopic Pregnancy

While Pratia Purpurascens prevents most pregnancies, if a failure occurs, there is a high likelihood (up to 50% in some data sets) that the pregnancy will be ectopic. Ectopic pregnancies can cause internal bleeding and are life-threatening. Any patient with the device who experiences lower abdominal pain and a missed period must be evaluated immediately.

Sepsis and Infection

Serious, life-threatening infections (including Group A Streptococcal Sepsis) have been reported following IUD insertion. If a patient develops severe pain or high fever within days of insertion, immediate medical intervention is required.

Wilson's Disease

Patients with Wilson’s disease, a rare genetic disorder that causes copper to accumulate in the liver, brain, and other vital organs, must not use Pratia Purpurascens. The additional copper release, though small, could exacerbate the condition.

MRI Safety

Pratia Purpurascens is considered 'MR-Conditional.' This means a patient can safely undergo an MRI scan, but they must inform the technician that they have a copper IUD so the appropriate settings can be used to prevent heating or image distortion.

Patients should be scheduled for a follow-up visit approximately 4 to 12 weeks after insertion to check for proper placement and to discuss any side effects. Following this, an annual pelvic exam is recommended. Patients should be taught how to perform a monthly 'string check' to ensure the device has not moved or been expelled.

Pratia Purpurascens has no known effect on the ability to drive or operate heavy machinery. However, immediately following insertion, some patients may feel dizzy or lightheaded. It is advised to wait until these feelings pass before driving.

There are no known interactions between alcohol and Pratia Purpurascens. Alcohol does not affect the contraceptive efficacy of the copper ions.

Pratia Purpurascens can be discontinued at any time by having a healthcare provider remove the device. Tapering is not required. Fertility returns to the patient's baseline immediately upon removal. If the device is being removed and the patient does not wish to become pregnant, removal should occur during a menstrual period or a backup method should be used for 7 days prior to removal.

> Important: Discuss all your medical conditions, including any history of pelvic infections or copper allergies, with your healthcare provider before starting Pratia Purpurascens.

There are no absolute drug-drug contraindications that would necessitate the immediate avoidance of Pratia Purpurascens, as its action is localized. However, the device itself is contraindicated in patients currently receiving trastuzumab if they have a known hypersensitivity to copper, though this is rare.

Anticoagulants and Antiplatelets

Drugs such as warfarin (Coumadin), clopidogrel (Plavix), or apixaban (Eliquis) may increase the risk of heavy menstrual bleeding (menorrhagia) in users of Pratia Purpurascens. Because the copper IUD already increases menstrual flow, the combination can lead to significant blood loss and anemia. Healthcare providers should monitor hemoglobin levels closely in these patients.

Immunosuppressants

Patients taking high-dose corticosteroids (e.g., prednisone) or other immunosuppressants (e.g., methotrexate, cyclosporine) may have a diminished immune response. Since the IUD relies on a localized inflammatory response and requires a healthy immune system to prevent secondary infection at the insertion site, these patients may be at a slightly higher risk of pelvic infection.

NSAIDs (Nonsteroidal Anti-inflammatory Drugs)

While NSAIDs like ibuprofen or naproxen are frequently used to treat the cramping associated with Pratia Purpurascens, some theoretical studies suggested they might interfere with the 'inflammatory' contraceptive mechanism. However, clinical evidence has shown that regular use of NSAIDs does NOT reduce the contraceptive efficacy of copper IUDs. They remain the first-line treatment for IUD-related pain.

There are no known food interactions with Pratia Purpurascens. Dietary copper intake does not affect the release rate of copper from the intrauterine device, nor does the device affect the absorption of dietary nutrients.

There are no documented interactions between Pratia Purpurascens and common herbal supplements like St. John's Wort, Ginkgo Biloba, or Valerian Root. Unlike hormonal birth control, the efficacy of the copper IUD is not compromised by liver enzyme-inducing herbs because it does not rely on hepatic metabolism.

Pratia Purpurascens does not typically interfere with standard blood or urine laboratory tests. However, the presence of the device may be visible on various imaging studies:

• X-ray/CT Scan: The copper wire is radiopaque and will be clearly visible in the pelvic region.
• Ultrasound: The T-frame and copper are highly echogenic, allowing for easy verification of placement.
• MRI: As noted, it may cause minor 'artifacts' (distortions) in the image of the pelvic area.

For each major interaction, the management strategy usually involves symptomatic treatment (e.g., iron supplements for anemia) rather than removal of the device, unless the symptoms become intolerable for the patient.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially if you are on blood thinners or treatments that affect your immune system.

Pratia Purpurascens must NEVER be used in the following circumstances:

1. 1Pregnancy: Use during pregnancy can lead to severe infection, miscarriage, or maternal death. A pregnancy test must be negative before insertion.
2. 2Uterine Abnormalities: Conditions that distort the uterine cavity (e.g., large fibroids, bicornuate uterus) prevent proper placement and increase the risk of expulsion or perforation.
3. 3Acute Pelvic Inflammatory Disease (PID): Insertion during an active infection can lead to life-threatening sepsis.
4. 4Unexplained Vaginal Bleeding: Before an IUD is inserted, the cause of any abnormal bleeding must be diagnosed to rule out malignancy (cancer).
5. 5Wilson's Disease: This genetic disorder of copper metabolism is an absolute contraindication due to the systemic risks of copper accumulation.
6. 6Copper Allergy: Individuals with a documented allergy to copper metal must not use this device.
7. 7Current Uterine or Cervical Cancer: The device can interfere with treatment and may exacerbate the condition.

Conditions requiring a careful risk-benefit analysis by a healthcare provider include:

• History of Ectopic Pregnancy: While the IUD prevents most pregnancies, a history of ectopic pregnancy increases the risk if the IUD fails.
• Multiple Sexual Partners: This increases the baseline risk of STIs, which can be more severe if an IUD is in place.
• Severe Dysmenorrhea: Patients with already painful or heavy periods may find that Pratia Purpurascens makes these symptoms intolerable.
• Anemia: Patients with low iron stores should be monitored closely due to the risk of increased blood loss.

Patients who have had a hypersensitivity reaction to other copper-containing medical devices (such as certain dental amalgams or older IUD models) may experience a cross-allergic reaction to Pratia Purpurascens. Symptoms may include localized inflammation or systemic rash.

> Important: Your healthcare provider will evaluate your complete medical history, including a physical exam and potentially an ultrasound, before prescribing Pratia Purpurascens.

Pratia Purpurascens is contraindicated during pregnancy. It is classified as Pregnancy Category X (in older systems). If a patient becomes pregnant with the device in place, the device should be removed immediately if the strings are visible. Removal carries a small risk of miscarriage, but leaving the device in place carries a much higher risk of septic abortion, which can be fatal. There is no evidence that copper from the IUD causes birth defects in pregnancies that continue to term with the device in place.

Pratia Purpurascens is considered safe for use during breastfeeding. Copper is a natural component of breast milk, and the tiny amount of copper released by the device does not significantly change the copper concentration in milk or affect the nursing infant. There is a slightly increased risk of uterine perforation if the device is inserted while a patient is lactating, likely due to the hormonal environment making the uterine wall thinner; clinicians should exercise extra caution during insertion.

Pratia Purpurascens is safe and effective for post-menarchal pediatric patients. It is often recommended as a first-line contraceptive for adolescents by organizations like the American Academy of Pediatrics (AAP) because it removes the need for daily compliance. The main consideration in this population is the smaller size of the uterus and the higher rate of expulsion compared to adult women.

This device is not intended for geriatric use. It should be removed once a woman is confirmed to be post-menopausal (typically after 12 consecutive months without a period).

No special precautions or dose adjustments are needed for patients with renal impairment. The localized nature of the copper release ensures that kidney function does not impact the safety or efficacy of the device.

No special precautions are needed for patients with hepatic impairment, with the sole exception of Wilson's Disease. In standard liver disease (e.g., hepatitis, cirrhosis), the device is safe to use as it is not metabolized by the liver.

> Important: Special populations, particularly those who are breastfeeding or in the adolescent age group, require individualized medical assessment to ensure the device is placed safely and monitored correctly.

Pratia Purpurascens acts as a spermicide and an intrauterine contraceptive through the release of copper ions (Cu2+). The molecular mechanism involves the inhibition of various enzymes within the sperm, particularly those required for carbohydrate metabolism and motility. The copper ions also induce a local sterile inflammatory response. This results in an increase in the concentration of lysosomal enzymes and other inflammatory mediators in the uterine fluid, which are toxic to sperm. Furthermore, the copper ions alter the cervical mucus, making it less penetrable by sperm, and modify the endometrial lining to prevent the implantation of a blastocyst.

The contraceptive effect of Pratia Purpurascens is immediate upon insertion. There is no 'lead-in' period required for efficacy. The duration of effect is constant as long as the device remains in the uterus and the copper has not been depleted. Tolerance does not develop, and the device does not interfere with the hypothalamic-pituitary-ovarian axis, meaning it does not suppress the natural production of hormones or the release of eggs (ovulation).

| Parameter | Value |

|---|---|

| Bioavailability | N/A (Local Action) |

| Daily Copper Release | 40-50 mcg/day |

| Systemic Absorption | Clinically Insignificant |

| Half-life | N/A (Device-based) |

| Tmax | N/A |

| Metabolism | None (Elemental) |

| Excretion | Vaginal/Menstrual |

The active component is elemental copper (Cu) with a purity of at least 99.9%. The frame is composed of medical-grade, low-density polyethylene mixed with barium sulfate (to make it visible on X-rays). The molecular weight of copper is 63.546 g/mol. Copper is insoluble in water but slowly corrodes in the acidic environment of the uterine fluid to release ions.

Pratia Purpurascens is classified as a Copper-containing Intrauterine Device [EPC]. It belongs to the broader category of Long-Acting Reversible Contraceptives (LARC). It is the only non-hormonal LARC currently available that provides protection for a decade.